Form D · Biotechnology
AB Science S.A.
Paris, I0 · CIK 0001703850
Offering snapshot reported Jul 17, 2026 · SEC filing
- Reported sold
- $2.02M Offering amount: $2.02M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 3, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 17, 2026 | Initial | $2,016,160 | No comparison | 2 | SEC filing |
| May 18, 2026 | Initial | $2,989,368 | No comparison | 2 | SEC filing |
| Apr 14, 2017 | Initial | $16,299,000 | No comparison | 11 | SEC filing |
| Apr 14, 2017 | Initial | $20,284,415 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $159K
- Finders' fees
- $0
- Form D file number
- 021-591326
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Maxim Group, LLC | 120708 |
Source: Form D, filed Jul 17, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alexis Bernard | Executive |
| Beatrice Bihr | Director |
| Cecile De Guillebon | Director |
| Christian Fassotte | Executive |
| Laurent Guy | Executive |
| Catherine Johnston Roussillon | Director |
| Jean Pierre Kinet | Director |
| Guillemette Latscha | Director |
| Stephane Ledermann | Director, Executive |
| Emmanuelle Mourey | Director |
| Patrick Moussy | Director |
| Alain Moussy | Director |
| Brigitte Reverdin | Director |
| Nathalie Riez | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3, Avenue George V
Paris, I0, 75008
Phone: 33 (0)1 47 20 00 14
Paris, I0, 75008
Phone: 33 (0)1 47 20 00 14